Email not displaying correctly? Click here to view it in your browser.
Therakos Mallinckrodt

Therakos ECP-day

Clinical, regulatory and economic overview of THERAKOS® photopheresis

Therakos Mallinckrodt

Rome, 29th September 2016

Hilton Rome Airport Hotel

The information in this email is intended only for healthcare professionals in
Europe, the Middle East and Asia Pacific.

THERAKOS® Photopheresis and the Outcomes
10.15 – 10.45
Therakos’ support to the photopheresis clinical evidence.
A Medical Affairs overview

Francesca Gennari, Medical Affairs, Therakos
10.45 – 11.15
THERAKOS® Photopheresis in the Rotherham experience
Dr. Peter Taylor, Rotherham, UK
11.15 – 11.45
Treating adult patients with THERAKOS® CELLEX® Photopheresis System
Dr. Francesco Ipsevich, Rome
11.45 – 12.15
Treating pediatric patients with THERAKOS® CELLEX® Photopheresis System
Dr. Stefano Ceccarelli, Rome
THERAKOS® Photopheresis and Regulations
12.15 – 12.45
Structural, procedural and organizational requirements of the photopheresis procedure, according to the EU and national "cells and tissue" regulations
Dr. Aurora Vassanelli, Verona
12.45 – 13.15
13.15 – 13.45
THERAKOS® CELLEX® Photopheresis System compliance with both “Cells and Tissue” and medicinal products regulations. Implications of CE mark and drug product authorization on patient’s safety
Raquel Carnero, Regulatory Affairs, Therakos
13.45 – 14.15
The Quality management of a photopheresis procedure
Dr. Michele Vacca, Rome
THERAKOS® Photopheresis and Economics
14.15 – 14.45
An analysis of the overall cost of the photopheresis procedure
Dr. Ivo Gentilini, Bolzano
14.45 – 15.15
The economic value of an integrated photopheresis system
Oscar Mesa, Health & Economics, Therakos
The Therakos Service
15.15 – 15.45
Therakos Science and Technology: the Value of All-in-one Support
Monica Minguzzi, Science & Technology, Therakos
Inês Sa, Global Advocacy & Education, Therakos
Wrap up and closure

Learn more about Mallinckrodt Pharmaceuticals by visiting
Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company.
Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2016 Mallinckrodt.

Privacy policy   Legal notice
If you would prefer not to receive e-documents from us in the future please reply with the word 'Unsubscribe'

© 2016 THERAKOS, Inc.